73 related articles for article (PubMed ID: 9050339)
1. Studies on metabolism of directly labeled 99mTc-antibody in mice.
Xue LY; Noujaim AA; Sykes TR; Woo TK; Peng Z
Q J Nucl Med; 1996 Dec; 40(4):341-50. PubMed ID: 9050339
[TBL] [Abstract][Full Text] [Related]
2. Role of transchelation in the uptake of 99mTc-MAb in liver and kidney.
Xue LY; Noujaim AA; Sykes TR; Woo TK; Wang XB
Q J Nucl Med; 1997 Mar; 41(1):10-7. PubMed ID: 9195848
[TBL] [Abstract][Full Text] [Related]
3. Effect of metabolism on retention of indium-111-labeled monoclonal antibody in liver and blood.
Kinuya S; Jeong JM; Garmestani K; Saga T; Camera L; Brechbiel MW; Gansow OA; Carrasquillo JA; Neumann RD; Paik CH
J Nucl Med; 1994 Nov; 35(11):1851-7. PubMed ID: 7965168
[TBL] [Abstract][Full Text] [Related]
4. Bis(hydroxamamide)-based bifunctional chelating agent for 99mTc labeling of polypeptides.
Xu LC; Nakayama M; Harada K; Kuniyasu A; Nakayama H; Tomiguchi S; Kojima A; Takahashi M; Ono M; Arano Y; Saji H; Yao Z; Sakahara H; Konishi J; Imagawa Y
Bioconjug Chem; 1999; 10(1):9-17. PubMed ID: 9893958
[TBL] [Abstract][Full Text] [Related]
5. Intracellular metabolic fate of radioactivity after injection of technetium-99m-labeled hydrazino nicotinamide derivatized proteins.
Ono M; Arano Y; Uehara T; Fujioka Y; Ogawa K; Namba S; Mukai T; Nakayama M; Saji H
Bioconjug Chem; 1999; 10(3):386-94. PubMed ID: 10346868
[TBL] [Abstract][Full Text] [Related]
6. Tumor uptake and metabolism of copper-67-labeled monoclonal antibody chCE7 in nude mice bearing neuroblastoma xenografts.
Novak-Hofer I; Zimmermann K; Maecke HR; Amstutz HP; Carrel F; Schubiger PA
J Nucl Med; 1997 Apr; 38(4):536-44. PubMed ID: 9098198
[TBL] [Abstract][Full Text] [Related]
7. 99mTc-labeling and in vitro and in vivo evaluation of HYNIC- and (Nalpha-His)acetic acid-modified [D-Glu1]-minigastrin.
von Guggenberg E; Behe M; Behr TM; Saurer M; Seppi T; Decristoforo C
Bioconjug Chem; 2004; 15(4):864-71. PubMed ID: 15264875
[TBL] [Abstract][Full Text] [Related]
8. Bifunctional NHS-BAT ester for antibody conjugation and stable technetium-99m labeling: conjugation chemistry, immunoreactivity and kit formulation.
Eisenhut M; Lehmann WD; Becker W; Behr T; Elser H; Strittmatter W; Steinsträsser A; Baum RP; Valerius T; Repp R; Deo Y
J Nucl Med; 1996 Feb; 37(2):362-70. PubMed ID: 8667077
[TBL] [Abstract][Full Text] [Related]
9. Direct labeling of monoclonal antibodies with technetium-99m by photoactivation.
Sykes TR; Woo TK; Baum RP; Qi P; Noujaim AA
J Nucl Med; 1995 Oct; 36(10):1913-22. PubMed ID: 7562064
[TBL] [Abstract][Full Text] [Related]
10. Technetium-99m labelling of the IOR CEA 1 monoclonal antibody: evaluation of different methods.
Gano L; Fernandes C; Cantinho G; Santos AI; Pena H; Vieira R; Salgado L; PatrÃcio L
Nuklearmedizin; 1997 Sep; 36(6):205-12. PubMed ID: 9380538
[TBL] [Abstract][Full Text] [Related]
11. Subcellular distribution and metabolism studies of the potential myocardial imaging agent [99mTc(N)(DBODC)(PNP5)]+.
Bolzati C; Cavazza-Ceccato M; Agostini S; Tokunaga S; Casara D; Bandoli G
J Nucl Med; 2008 Aug; 49(8):1336-44. PubMed ID: 18632814
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution study of 188Re-labeled trisuccin-HuCC49 and trisuccin-HuCC49deltaCh2 conjugates in athymic nude mice bearing intraperitoneal colon cancer xenografts.
Safavy A; Khazaeli MB; Safavy K; Mayo MS; Buchsbaum DJ
Clin Cancer Res; 1999 Oct; 5(10 Suppl):2994s-3000s. PubMed ID: 10541333
[TBL] [Abstract][Full Text] [Related]
13. Radiolabeled humanized anti-CD3 monoclonal antibody visilizumab for imaging human T-lymphocytes.
Malviya G; D'Alessandria C; Bonanno E; Vexler V; Massari R; Trotta C; Scopinaro F; Dierckx R; Signore A
J Nucl Med; 2009 Oct; 50(10):1683-91. PubMed ID: 19759100
[TBL] [Abstract][Full Text] [Related]
14. Biological properties of biotin-chelate conjugates for pretargeted diagnosis and therapy with the avidin/biotin system.
Goodwin DA; Meares CF; Osen M
J Nucl Med; 1998 Oct; 39(10):1813-8. PubMed ID: 9776294
[TBL] [Abstract][Full Text] [Related]
15. Studies on the uptake mechanisms of 99mTc-labeled antibodies by liver tissue.
Xue LY; Noujaim AA; Sykes TR; Peng Z
Q J Nucl Med; 1996 Jun; 40(2):176-81. PubMed ID: 8909103
[TBL] [Abstract][Full Text] [Related]
16. Targeting strategies for cancer radiotherapy.
Buchsbaum DJ; Rogers BE; Khazaeli MB; Mayo MS; Milenic DE; Kashmiri SV; Anderson CJ; Chappell LL; Brechbiel MW; Curiel DT
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3048s-3055s. PubMed ID: 10541342
[TBL] [Abstract][Full Text] [Related]
17. Radiation dosimetry of a 99mTc-labeled IgM murine antibody to CD15 antigens on human granulocytes.
Mozley PD; Stubbs JB; Dresel SH; Barraclough ED; Smith T; Patel M; Finkelman C; Sparks RB; Thakur ML; Mathur A; Alavi A
J Nucl Med; 1999 Apr; 40(4):625-30. PubMed ID: 10210221
[TBL] [Abstract][Full Text] [Related]
18. Organ distribution of 99mTc- and 51Cr-labeled autologous peripheral blood lymphocytes in rabbits.
Gobuty AH; Robinson RG; Barth RF
J Nucl Med; 1977 Feb; 18(2):141-6. PubMed ID: 833659
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral distribution of radiolabeled antibody and radioimmunotherapy in experimental liver metastases model of nude mouse.
Sato N; Saga T; Sakahara H; Yao Z; Nakamoto Y; Zhang M; Kuroki M; Matsuoka Y; Iida Y; Konishi J
J Nucl Med; 1999 Apr; 40(4):685-92. PubMed ID: 10210230
[TBL] [Abstract][Full Text] [Related]
20. Effects of linker chemistry on the pharmacokinetics of radioimmunoconjugates.
Quadri SM; Vriesendorp HM
Q J Nucl Med; 1998 Dec; 42(4):250-61. PubMed ID: 9973840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
